Sign Up to like & get
recommendations!
0
Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.0955
Abstract: Key Points Question Is gender-affirming hormone therapy (GAHT) associated with lower rates of moderate to severe depressive symptoms in transgender, nonbinary, and gender diverse (TGD) adults in primary care? Findings In this cohort study of…
read more here.
Keywords:
hormone therapy;
gender affirming;
affirming hormone;
depressive symptoms ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Journal of homosexuality"
DOI: 10.1080/00918369.2023.2186759
Abstract: Gender Affirming Hormone Therapy (GAHT) is a key therapeutic approach which aims to help trans and gender diverse (or simply "trans") individuals' transition from their sex-presumed-at-birth to their experienced gender identity. Previous reviews have focused…
read more here.
Keywords:
affirming hormone;
gender affirming;
gender;
gaht ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "AIDS research and human retroviruses"
DOI: 10.1089/aid.2022.0044
Abstract: Transgender persons have an increased vulnerability to HIV infection yet have not been well-represented in past clinical trials for pre-exposure prophylaxis (PrEP). Because of this, there are few data available to understand whether gender-affirming hormone…
read more here.
Keywords:
daily tdf;
hormone;
affirming hormone;
gender affirming ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Obstetrics and Gynecology"
DOI: 10.1097/grf.0000000000000398
Abstract: There are an estimated 1.4 million transgender adults in the United States, and lack of providers knowledgeable in transgender care is a barrier to health care. Obstetricians and Gynecologists can help increase access in part…
read more here.
Keywords:
transgender;
affirming hormone;
gender affirming;
hormone therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000002442
Abstract: Background: Medical affirmation, including gender-affirming hormones, is an essential component in the treatment of many transgender and gender-diverse youth. The risk of venous thromboembolism (VTE) during testosterone therapy for gender-affirming care is not fully elucidated.…
read more here.
Keywords:
testosterone therapy;
hormone treatment;
affirming hormone;
transgender ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Internal medicine journal"
DOI: 10.1111/imj.70194
Abstract: Using longitudinal national prescribing data, we estimated the number of transgender and gender‐diverse individuals initiating gender‐affirming hormone therapy (GAHT) from 2013 to 2024 in Australia. Between 2013 and 2024, 11 883 individuals initiated testosterone‐based GAHT and…
read more here.
Keywords:
hormone therapy;
gender affirming;
initiation;
affirming hormone ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Internal Medicine"
DOI: 10.1111/joim.13441
Abstract: In line with increasing numbers of transgender (trans) and gender nonbinary people requesting hormone treatment, the body of available research is expanding. More clinical research groups are presenting data, and the numbers of participants in…
read more here.
Keywords:
hormone;
review;
literature review;
affirming hormone ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-060869
Abstract: Introduction Gender affirming hormone therapy (GAHT) is increasingly used by transgender individuals and leads to shifts in sex hormone levels. Skeletal muscle is highly responsive to hormone activity, with limited data on the effects of…
read more here.
Keywords:
muscle;
affirming hormone;
gender affirming;
skeletal muscle ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Physiology"
DOI: 10.1152/physiol.2023.38.s1.5731234
Abstract: Gender-Affirming Hormone Therapy (GAHT) in transgender females (male to female) involves administration of 17ß-estradiol (E2) with an anti-androgen (AA) or castration (CTX). GAHT is used to treat individuals that are born one sex but identify…
read more here.
Keywords:
male;
physiology;
risk;
ctx ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal of the Endocrine Society"
DOI: 10.1210/jendso/bvae163.1586
Abstract: Abstract Disclosure: A. Jain: None. M.S. Irwig: None. Many Transgender and Gender Diverse (TGD) individuals take Gender Affirming Hormone Therapy (GAHT). A study that included 264 adults [67% assigned male at birth (AMAB)] in Georgia…
read more here.
Keywords:
hormone therapy;
affirming hormone;
gender;
gender affirming ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Pediatrics"
DOI: 10.1542/peds.2023-064380
Abstract: OBJECTIVES Guidelines for monitoring of medications frequently used in the gender-affirming care of transgender and gender-diverse (TGD) adolescents are based on studies in adults or other medical conditions. In this study, we aimed to investigate…
read more here.
Keywords:
hormone therapy;
affirming hormone;
gender affirming;
transgender ... See more keywords